Clinical trial
Effect of Albumin Administration on Outcomes in Hypoalbuminemic Patients Hospitalized With Community-acquired Pneumonia (ALBUCAP): a Prospective, Randomized, Phase III Clinical Controlled Trial.
NCT04071041 is registered in ClinicalTrials.gov with Jordi Carratala as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Albumin Administration on Outcomes in Hypoalbuminemic Patients Hospitalized With Community-acquired Pneumonia (ALBUCAP): a Prospective, Randomized, Phase III Clinical Controlled Trial.
- Lead sponsor
- Jordi Carratala
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- October 31, 2019
- Completion date
- October 31, 2021
- Enrollment
- 39 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.